The methodology we followed, in combination with the small size of CD8 positive tumors in our study, suggest that the prognostic significance of TILs between Ki67-high and Ki67-low breast cancers remains to be elucidated in a large series of patients. This evidence concerns the gene CD8A and breast cancer.